Present status of clinical pharmacology and of regulatory requirements for preclinical and clinical evaluation of new drugs in Japan.
D000970:Antineoplastic Agents; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D006077:Government Agencies; D007564:Japan; D007880:Legislation, Drug; D007928:Lethal Dose 50; D010600:Pharmacology; D010606:Pharmacy and Therapeutics Committee; D010820:Physicians; D013723:Teratogens; D014116:Toxicology
D000970:Antineoplastic Agents; D013723:Teratogens